DEVELOPMENT AND INNOVATION IN CARDIOVASCULAR MEDICINE - Innovation in the Biopharmaceutical Industry - page 44

Tillet, WS and S Sherry (1949). The effect in patients of streptococcal fibrinolysin (strep-
tokinase) and streptococcal desoxyribonucease on fibrinous, purulent and sanguinous
pleural exudations. The Journal of Clinical Investigation , 28, 173.
Tobis, JM, JA Mallery, J Gessert, J Griffith, D Mahon, M Bessen, M Moriuchi, L McLeay,
M McRae and WL Henry (1989). Intravascular ultrasound cross-sectional arterial
imaging before and after balloon angioplasty in vitro. Circulation , 80, 873-882.
Waller, AD (1887). A demonstration on man of electromotive changes accompanying the
heart's beat. The Journal Physiology (London) , 8, 229-234.
Yusef, S, P Sleight, J Pogue, J Bosch, R Davies and G Dagenais (2000). Effects of an
angiotensin converting enzyme inhibitor, ramapril on cardiovascular events in high
risk patients. The Heart Outcomes Prevention Evaluation Study Investigation. The
New England Journal of Medicine , 342, 145-153.